Sumit Kumar

Sumit Kumar, PhD, is a Senior Scientist in In Vivo Pharmacology at AstraZeneca, specializing in immuno-oncology. They have over 10 years of experience in onco-immunology, highlighted by their work with pre-clinical solid tumor models and immune cell-based assays. Sumit earned a PhD in Biochemistry and Molecular Biology from Heidelberg University, where they conducted extensive research on protein interactions and signaling. Previous roles include postdoctoral research at Leiden University Medical Center and the Max Planck Institutes, where they developed innovative biochemical assays and supervised students. Their strong interpersonal skills enhance their ability to communicate complex scientific concepts to diverse audiences.